Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish
Farmovs
In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19. 

The trial is expected to include more than 45 countries worldwide, including a number of South African sites. 

Farmovs

FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.   

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients. 

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.  FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.


News Archive

Advocate Thuli Madonsela leads Law Symposium on corruption
2014-06-05

 

Advocate Thuli Madonsela speaking at the Law Symposium on corruption.

The Faculty of Law, Centre of Business Law held a symposium on corruption in the public sector. The symposium took place on 5 June 2014 in the CR Swart Auditorium on the Bloemfontein Campus.

In her keynote address, Public Protector Adv Thuli Madonsela highlighted the government’s efforts to curb the high rate of corruption prevalent in the South African public sector. She also pointed out the effect it has had on service delivery, especially in municipalities and key government departments.

This highly-anticipated event drew a large group consisting of members of the public, the judiciary, government, non-governmental organisations, as well as the business and academic sector.

Responding to questions from the floor, Adv Madonsela spoke of corruption as an on-going problem that should be tackled in a collective effort by government officials and the public alike. “Whistleblowers are our main hope in fighting corruption … The Protected Disclosures Act protects them … it is also management’s responsibility to protect whistleblowers,” she said.

The symposium featured several well-respected names, including:
• Prof Jonathan Jansen, Vice-Chancellor and Rector;
• Honourable Justice I van der Merwe, Judge of the Free State High Court and Chairman of the Council of the UFS;
• Honourable Justice FDJ Brand, Judge of the Supreme Court of Appeal; and
• Prof JJ Henning, Acting Dean of the Faculty of Law.

Other high-ranking legal professionals from the office of the Director of Public Prosecutions, PriceWaterhouseCoopers, the Free State High Court and the Institute of Security Studies attended the event.


We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept